Clinical Trials Logo

Pancreatic Cancer Pain clinical trials

View clinical trials related to Pancreatic Cancer Pain.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT01615653 Completed - Clinical trials for Pancreatic Cancer Pain

EUS Guided Celiac Neurolysis

Start date: September 2009
Phase: N/A
Study type: Interventional

- Hypothesis: - Direct CGN enhances neurolytic drug delivery into celiac ganglia and increases the efficacy of neurolysis and subsequent pain control and survival in patients with pancreatic carcinoma. - Rationale: - Standard CPN leads to inaccurate delivery of the injectate with rapid dispersal thereby only briefly remaining in contact with neural structures and limiting the degree of neurolysis. Poor targeting and delivery of a neurolytic agent may result in diminished neurolysis and decrease efficacy.